Trump confident ahead of Monday showdown, says Dems’ position makes shutdown likely

Washington — President Trump said Sunday that a government shutdown is likely unless top Democrats back down from their negotiating position.

“I just don’t know how we are going to solve this issue,” Mr. Trump said in a phone interview with CBS News.

Mr. Trump also expressed confidence that the American people will side with him if government funding expires in the coming days. He believes Democrats will pay a political price for not working with him, on his terms, to further cut spending.

“They’re not interested in fraud, waste and abuse,” Mr. Trump said of the Democrats.

The president is scheduled to meet Monday with congressional leaders ahead of the Oct. 1 deadline for lawmakers to reach an agreement on a spending bill that would avert a shutdown.

A source close to Mr. Trump told CBS News that the president privately welcomes the prospect of a shutdown because it will enable him to wield executive power to slash some government programs and salaries.

Last week, the White House Office of Management and Budget sent a memo to federal agencies instructing them to prepare layoff plans if there is a government shutdown. The memo, obtained by CBS News, directs agencies to consider reduction-in-force (RIF) notices—a federal term for layoffs—for employees in programs, projects, or activities with discretionary funding that stops on Oct. 1 or that lack alternative funding sources.

The memo further states that employees should receive RIF notices if they work in programs or projects “not consistent with the President’s priorities.”

In the interview Sunday, Mr. Trump criticized the Democrats’ current demands, which in recent weeks have focused on extending Affordable Care Act insurance subsidies, calling them ill-advised.

Instead, Mr. Trump said, if the Democrats want to discuss health care, they should work with him to prevent undocumented migrants from accessing public benefits.

“The Democrats, incredibly, want to keep their old policies of open borders and we’re not going to have it. We’re not going to allow it,” Mr. Trump said.

He added that any possible health-care negotiations must address immigration and border-related matters; otherwise, “It’s just not acceptable for us.”

Democrats have forcefully pushed back against Mr. Trump’s characterization of their positions on both government funding and immigration. They emphasize that people who are in the U.S. illegally are not eligible to receive Medicaid coverage.

“Donald Trump knows, or at least I think he knows, that current federal law prohibits using taxpayer dollars for undocumented immigrants in connection with their health care. And no one is trying to change or reverse that law,” House Minority Leader Hakeem Jeffries told MSNBC on Saturday.

“What we are doing is fighting to protect the healthcare of everyday Americans in the midst of this Republican-caused crisis that is devastating hospitals and nursing homes and community-based health clinics,” Jeffries added.

Mr. Trump is scheduled to meet Monday with Senate Majority Leader John Thune, Senate Minority Leader Chuck Schumer, House Speaker Mike Johnson, and Jeffries. The meeting comes after the president canceled an initial session last week, citing the Democrats’ “unserious and ridiculous” demands.

Earlier this month, the House approved a GOP-led continuing resolution to keep the government funded until Nov. 21. However, Democrats put forward their own proposal to keep the government funded until Oct. 31, including other party priorities such as their health-care request.

In the Senate, where 60 votes are needed to advance most legislation, both the House-passed bill and the Democrats’ proposal fell short.

The Democrats’ proposal includes a permanent extension of enhanced tax credits for Americans purchasing health insurance through the Affordable Care Act marketplace, which Democrats have described as a red line for their support.

The proposal would also roll back cuts to Medicaid in Mr. Trump’s “big, beautiful” bill and restore funding for public broadcasters that was rescinded earlier this year.

The Senate is returning to Washington on Monday after a weeklong recess and will have little time to act to avert a shutdown.

Echoing Mr. Trump, Senate Majority Leader John Thune told NBC’s “Meet the Press” that it’s “totally up to the Democrats” whether the government shuts down, noting “there is a bill sitting at the desk in the Senate right now” that the House passed to keep the government open.

“This decision, in my judgment at this point in time, is up to a handful of Democrats,” Thune said. “We need eight Democrats to pass it through the Senate.”

Senator Amy Klobuchar, a Minnesota Democrat, told “Face the Nation” Sunday that “Democrats are united in pushing” on the health-care issue and expressed optimism about the upcoming meeting.

“This is an opportunity for the country because of one big problem, and that is that the Republicans have created a health care crisis,” Klobuchar said. “My constituents, Americans, are standing on a cliff right now with these insurance premium increases that are upon them.”

— Contributed to this report
https://www.cbsnews.com/news/trump-confident-government-shutdown-meeting/

1,869% rally in 5 years! Do you own this stock?

**1,869% Rally in 5 Years! Do You Own This Stock?**

*By Dwaipayan Roy | Sep 28, 2025, 04:49 PM*

Cupid Limited has been making waves in the market, delivering stellar returns of over **244% in just six months** and an astounding **1,869% over five years**. This remarkable performance is expected to attract heightened interest in Monday’s trading session.

### What’s Driving Cupid Limited’s Growth?

The company’s Chairman and Managing Director, **Aditya Kumar Halwasiya**, recently announced that **Q2 FY26 is poised to be the best quarter in Cupid’s history**. This optimistic forecast is fueled by several key factors:

– New product launches
– Accelerating momentum in the FMCG vertical
– A strong pipeline of institutional orders

### Strong Financial Performance

Cupid Limited reported impressive financial results for the year, with a **total income of ₹203.18 crore** and a **net profit of ₹40.89 crore**. The company has also experienced rapid growth in its B2C FMCG segment, generating over **₹50 crore in revenue within just one year**.

This success is supported by a vast distribution network of **1.2 lakh retail outlets across India**, enabling strong consumer connect and an expanding market presence.

### A Strategic Shift Towards Wellness and Health-Tech

Halwasiya emphasized Cupid’s transformation from being primarily a contraceptive company to establishing itself as a leader in **consumer wellness and health-tech**.

He highlighted the company’s focus on:

– Sustainable growth
– Global expansion
– Innovation

while ensuring **personal care and preventive healthcare remain accessible to all**.

Cupid Limited’s strong fundamentals and visionary leadership position it well for continued growth and market success. Investors may want to keep a close watch on this evolving company.
https://www.newsbytesapp.com/news/business/cupid-limited-to-report-best-ever-quarter-stock-up-244/story

Need to integrate trans-inclusive science in medical education, says study

**Integrating Trans-Inclusive Science in Medical Education: A Crucial Step for India’s Healthcare System**

NEW DELHI: Transgender individuals in India routinely face discrimination in healthcare, often encountering prejudice and ignorance from medical providers. Addressing this issue, a recent study published in the American journal *Advances in Physiology Education* emphasizes the urgent need to integrate trans-inclusive science early within India’s medical curricula. This integration is essential to adequately meet the specific medical needs of transgender people.

Globally, many medical schools dedicate minimal to no hours to LGBT health education. India is no exception. Despite the Transgender Persons (Protection of Rights) Act, 2019—which prohibits discrimination—transgender individuals continue to face barriers in education and healthcare.

To tackle this challenge, a first-of-its-kind study was conducted in India, offering fresh hope if its recommendations are incorporated into medical education. Dr. Satendra Singh, Director Professor of the Department of Physiology at the University College of Medical Sciences and GTB Hospital in Delhi, and one of the study’s authors, highlighted the shortcomings of the National Medical Commission (NMC), the body that regulates medical education in India.

“The NMC has failed to adequately address LGBT health,” Dr. Singh said. “Unfortunately, the NMC has made repeated U-turns on including LGBTQI content in the Competency-Based Medical Education (CBME) curriculum, first in 2019 and again in 2024.”

According to the 2011 census, India has approximately 4.88 lakh transgender persons. This study is the first in the country to longitudinally integrate trans-affirmative competencies into the MBBS physiology curriculum, marking a significant milestone for medical education in India.

Dr. Singh was recently honored with the prestigious WHO South-East Asia Region award for Public Health Champion in the individual category, recognizing his efforts in championing disability inclusion within health systems and medical education.

The pilot study employed a mixed-methods approach to integrate trans-affirmative competencies into the MBBS physiology curriculum, explained the study’s primary author, Dr. Athul KM, based in Kozhikode.

Co-author Prof. (Dr.) Aqsa Shaikh, Professor of Community Medicine at Hamdard Institute of Medical Sciences and Research, added, “From dehumanization in the old curriculum to a human-centered approach in this pilot, we have taken a small step in the right direction.”

The findings from this study highlight a critical path forward for transforming India’s medical education system—towards inclusivity, sensitivity, and comprehensive care for transgender individuals.
https://www.newindianexpress.com/thesundaystandard/2025/Sep/28/need-to-integrate-trans-inclusive-science-in-medical-education-says-study

How Trump’s H-1B fee hike could affect US healthcare system

**How Trump’s H-1B Fee Hike Could Affect the US Healthcare System**
*By Akash Pandey | Sep 20, 2025, 05:03 PM*

The Trump administration has announced a staggering increase in the annual fee for H-1B visas, raising it by $100,000. This move is poised to have severe implications for the US healthcare system, where over 30% of medical residents are international graduates.

Currently, approximately 10,000 out of 43,000 residency spots are occupied by H-1B visa holders. With the visa fee surge—from less than $5,000 to an eye-watering $100,000—many hospitals may find it economically unfeasible to sponsor these visas for medical residents, who earn an average annual salary of around $55,000. This could exacerbate existing staffing shortages and ultimately compromise patient care. As Commerce Secretary Howard Lutnick noted, “No longer will you put trainees on an H-1B visa—it’s just not economic anymore.”

### Visa Costs Surge, Risking Patient Care

The dramatic hike in fees significantly raises costs for employers. It is expected to make the H-1B program viable only for high-value roles, rather than entry-level or trainee positions. Officials have yet to clarify whether the $100,000 fee will be charged upfront or annually. Meanwhile, visa quotas remain unchanged at 65,000 for regular applicants and 20,000 for advanced degree holders. However, the soaring costs are anticipated to cause a sharp decline in applications.

### Impact on Businesses and IT Firms

India remains the largest beneficiary of H-1B visas, accounting for 71% of approvals last year. The fee increase will likely impact IT companies such as Infosys, TCS, and Wipro, which frequently send junior and mid-level engineers to the US for projects.

According to recent data, Amazon leads with 10,044 H-1B visa holders, followed by TCS (5,505), Microsoft (5,189), Meta (5,123), Apple (4,202), Google (4,181), Deloitte (2,353), Infosys (2,004), Wipro (1,523), and Tech Mahindra Americas (951).

### Opposition and Criticism

The policy has drawn sharp criticism from US lawmakers and immigration advocates. Congressman Raja Krishnamoorthi described the fee hike as “reckless,” warning that it risks cutting the US off from high-skilled talent essential for innovation and job creation.

Ajay Bhutoria, a former advisor to President Joe Biden, added that the increase could “crush small businesses and start-ups reliant on diverse talent.” He also cautioned that it might drive skilled workers to Canada or Europe, thereby weakening America’s competitive edge globally.

The Trump administration’s hefty H-1B fee increase could thus have far-reaching consequences—not only for the US healthcare system struggling with staff shortages but also for the broader economy and the country’s position as a hub for global talent.
https://www.newsbytesapp.com/news/world/us-healthcare-braces-for-impact-as-trump-hikes-h-1b-fee/story

How Trump’s H-1B fee hike could affect US healthcare system

**How Trump’s H-1B Fee Hike Could Affect the US Healthcare System**
*By Akash Pandey | Sep 20, 2025, 05:03 PM*

The Trump administration has announced a staggering increase in the annual fee for H-1B visas, raising it by $100,000. This drastic move is expected to have severe implications for the US healthcare system, where over 30% of medical residents are international graduates.

Currently, around 10,000 out of 43,000 residency positions are occupied by H-1B visa holders. With the new fee hike, hospitals may find it financially unfeasible to sponsor these visas for residents earning an annual salary of approximately $55,000. This could intensify the existing staffing shortages and ultimately compromise patient care.

**Staffing Crisis: Visa Costs Surge, Risking Patient Care**

Previously, H-1B visa fees were less than $5,000. Commerce Secretary Howard Lutnick commented on the change, saying, “No longer will you put trainees on an H-1B visa — it’s just not economic anymore.” The increase poses a significant challenge to hospitals that rely on international medical graduates to fill crucial residency roles.

**Application Impact: Program Now Feasible Only for High-Value Roles**

The policy raises costs so substantially that the H-1B program may now only be viable for high-value roles. It remains unclear whether the $100,000 fee will be charged upfront or on an annual basis. While visa quotas remain unchanged—65,000 for regular applicants and 20,000 for advanced degree holders—officials expect a sharp decline in applications due to the prohibitive costs.

**Business Impact: IT Firms Likely to Be Most Affected**

India, which accounted for 71% of H-1B approvals last year, stands to be heavily impacted. Major IT firms like Infosys, TCS, and Wipro, which send large numbers of junior and mid-level engineers to the US, may face significant challenges under the new fee structure.

To illustrate, Amazon leads with 10,044 H-1B visa holders, followed by TCS (5,505), Microsoft (5,189), Meta (5,123), Apple (4,202), Google (4,181), Deloitte (2,353), Infosys (2,004), Wipro (1,523), and Tech Mahindra Americas (951).

**Opposition Response: Policy Draws Criticism**

The fee hike has sparked criticism from US lawmakers and immigration advocates. Congressman Raja Krishnamoorthi described the policy as “reckless,” warning that it could cut the US off from high-skilled talent essential for innovation and job creation.

Ajay Bhutoria, former advisor to President Joe Biden, cautioned that the increase might “crush small businesses and start-ups reliant on diverse talent” and push skilled workers to seek opportunities in Canada or Europe. This, he warned, could weaken America’s competitive edge in the global market.

The $100,000 H-1B visa fee hike represents a significant shift in immigration policy with far-reaching consequences, particularly for the US healthcare and IT sectors. Its full impact remains to be seen but is expected to challenge both employers and skilled foreign workers across the country.
https://www.newsbytesapp.com/news/world/us-healthcare-braces-for-impact-as-trump-hikes-h-1b-fee/story

How Trump’s H-1B fee hike could affect US healthcare system

**How Trump’s H-1B Fee Hike Could Affect the US Healthcare System**
*By Akash Pandey | Sep 20, 2025, 05:03 PM*

The Trump administration has announced a staggering increase in the annual fee for H-1B visas, raising it by $100,000. This unprecedented hike is expected to have severe implications for the US healthcare system, where over 30% of medical residents are international graduates.

Currently, approximately 10,000 out of 43,000 residency positions in the United States are occupied by H-1B visa holders. With the new fee soaring from less than $5,000 to $100,000 annually, hospitals may be deterred from sponsoring these visas for residents who earn an average salary of around $55,000. This change threatens to exacerbate the existing staffing shortages in the healthcare sector, potentially compromising patient care.

“No longer will you put trainees on an H-1B visa — it’s just not economic anymore,” said Commerce Secretary Howard Lutnick, highlighting the financial strain the fee hike places on medical institutions.

### Impact on the H-1B Program

The drastic increase in visa fees makes the H-1B program financially feasible only for high-value roles, effectively sidelining many junior and mid-level workers. While the administration has not yet clarified if the new $100,000 fee will be charged upfront or annually, officials anticipate a significant decline in application volumes.

Notably, visa quotas remain unchanged, with 65,000 regular H-1B visa spots and 20,000 reserved for advanced degree holders. However, the soaring costs raise questions about how many employers will continue to utilize the program.

### Business and Industry Effects

India remains the largest beneficiary of H-1B visas, accounting for 71% of approvals last year. The fee hike is likely to impact major IT firms such as Infosys, Tata Consultancy Services (TCS), and Wipro, which send numerous junior and mid-level engineers to the US for ongoing projects.

Leading companies by number of H-1B visa holders include:

– Amazon: 10,044
– TCS: 5,505
– Microsoft: 5,189
– Meta: 5,123
– Apple: 4,202
– Google: 4,181
– Deloitte: 2,353
– Infosys: 2,004
– Wipro: 1,523
– Tech Mahindra Americas: 951

The increased fees could disrupt talent pipelines and project deliveries, especially for companies relying on cost-effective international talent.

### Opposition and Criticism

The policy has drawn sharp criticism from US lawmakers and immigration advocates. Congressman Raja Krishnamoorthi condemned the move as “reckless,” warning that it could cut the US off from vital high-skilled talent essential for innovation and job creation.

Ajay Bhutoria, former advisor to President Joe Biden, expressed concerns that the fee hike could “crush small businesses and start-ups reliant on diverse talent,” pushing skilled workers to seek opportunities in Canada or Europe. This shift could significantly weaken America’s competitive edge in the global economy.

### Conclusion

The Trump administration’s dramatic increase in H-1B visa fees poses serious challenges to various sectors, with the healthcare system and technology firms standing to be hit hardest. As visa costs surge, the future of international talent participation in the US workforce hangs in the balance, raising critical questions about the nation’s ability to maintain its leadership in innovation and quality healthcare delivery.

*Stay tuned for more updates on immigration policies and their impact on the US economy.*
https://www.newsbytesapp.com/news/world/us-healthcare-braces-for-impact-as-trump-hikes-h-1b-fee/story

Indore’s SAIMS Takes A Big Stride In Healthcare Innovation

**SAIMS Indore to Become First Private Medical College in India to Produce Isotopes at Own Cyclotron Plant**

*Indore (Madhya Pradesh):* In a pioneering step towards healthcare innovation, Sri Aurobindo Institute of Medical Sciences (SAIMS), Indore, is set to become the first private medical college in the country to produce isotopes at its own cyclotron plant.

The isotopes, including gallium-based PET tracers, will be created using liquid gallium. These isotopes will play a vital role not only in advanced diagnostic procedures but also in treatment, with the added advantage of being free from side effects.

Dr. Vinod Bhandari, founder chairman of Sri Aurobindo University, shared this information while inaugurating an awareness campaign under National Pharmacovigilance Week organized by the department of pharmacology.

He said that in line with Prime Minister Narendra Modi’s vision of a developed India, SAIMS is introducing revolutionary measures to provide patients with world-class medical facilities.

### SAIMS Designated as Regional Pharmacovigilance Centre

Highlighting the institute’s role in drug safety, Dr. Bhandari added that the Government of India has designated SAIMS as the first Regional Pharmacovigilance Centre in Madhya Pradesh under its pharmacovigilance programme.

In the first phase, SAIMS has reported over 6,000 adverse drug reactions from 13 centres to the National Centre (IPC Ghaziabad) and the WHO Uppsala Monitoring Centre in Sweden. This data is being used by national and global health agencies for research and to improve patient safety.

### National Pharmacovigilance Week Awareness Campaign

The campaign coordinators, Dr. Chhaya Goel and Dr. Pooja Reddy, explained that the objective of the National Pharmacovigilance Week is to make patients more aware of possible side effects of medicines and encourage them to report adverse drug reactions.

They further clarified that adverse drug reactions do not reflect negatively on the doctor but instead provide crucial information that helps ensure safer and more effective prescriptions in the future.

Under the campaign, awareness sessions, scientific workshops, and interactive programmes are being conducted to engage both patients and healthcare professionals.

Senior faculty members including Dr. Raj Wavre (Dean, Medical College), Dr. Jayshree Tapadia (Dean, Student Welfare), Dr. Anuja Jha (Deputy Coordinator, Materiovigilance), Mohammad Rafi (Pharmacovigilance Associate), and Jitendra Patidar (Materiovigilance Associate) attended the event.

Sri Aurobindo Institute of Medical Sciences continues to lead in healthcare innovation and patient safety, contributing significantly to India’s goal of advanced medical care facilities.
https://www.freepressjournal.in/indore/indores-saims-takes-a-big-stride-in-healthcare-innovation

This AI predicts your disease risks 10 years in advance

### This AI Predicts Your Disease Risks 10 Years in Advance

**By Mudit Dube | Sep 18, 2025**

A team of scientists has developed a groundbreaking artificial intelligence (AI) tool capable of predicting an individual’s risk for over 1,000 diseases. The innovative system, dubbed **Delphi-2M**, can forecast health changes up to a decade in advance. The research, published in the journal *Nature*, highlights the potential of generative AI to model human disease progression on a large scale.

### How Delphi-2M Works

Delphi-2M uses algorithmic concepts similar to those found in large language models (LLMs). It predicts the likelihood of developing diseases such as cancer, diabetes, heart disease, and respiratory disorders by analyzing key “medical events” in a patient’s history—like diagnosis dates—and lifestyle factors, including obesity status, smoking or drinking habits, age, and sex.

The AI was trained on anonymized patient data from two major healthcare sources: the UK’s Biobank study, comprising 400,000 participants, and Denmark’s national patient registry, which includes 1.9 million patients.

### Potential Impact on Personalized Healthcare

Delphi-2M predicts health risks expressed as rates over time, much like weather forecasts. According to Ewan Birney, interim executive director of EMBL, patients could benefit from the tool within a few years. He envisions a future where clinicians use AI tools like Delphi-2M to identify major health risks early and suggest lifestyle changes to mitigate them.

This marks a significant step forward in personalized healthcare and disease prevention strategies.

### Advantages Over Existing Methods

Birney also emphasized Delphi-2M’s superiority compared to current risk assessment models such as Qrisk. Unlike single-disease models, Delphi-2M can assess multiple diseases simultaneously and provide predictions over an extended time frame.

The research team noted that Delphi-2M’s accuracy in predicting disease rates based on an individual’s past medical history rivals that of existing single-disease models.

### Future Prospects: Revolutionizing Healthcare with Generative Models

Professor Moritz Gerstung from the German Cancer Research Center described Delphi-2M as a major advancement in understanding human health and disease progression. He believes generative AI models like Delphi-2M could eventually personalize care and anticipate healthcare needs on a much larger scale.

This breakthrough underscores the transformative potential of AI tools in predicting individual health risks and enabling proactive healthcare management.

*Stay tuned for more updates on how AI is shaping the future of medicine and personalized health.*
https://www.newsbytesapp.com/news/science/delphi-2m-ai-tool-predicts-risk-of-over-1-000-diseases/story